Associations between enteral nutrition and outcomes in the SUP ‐ ICU trial: Results of exploratory post hoc analyses by Borthwick, M, Granholm, A, Marker, S, Krag, M, Lange, T, Wise, MP, Bendel, S, Keus, F, Guttormsen, AB, Schefold, JC, Wetterslev, J, Perner, A, Møller, MH

Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double‐blind, placebo‐controlled feasibility tri... by Desborough, MJR, Laing, E, Kounali, D, Mora, A, Hodge, R, Martin, S, Thomas, H, Hudson, C, Parsons, J, Shah, A, Hutton, P, Parke, T, Wise, MP, Morgan, M, McKechnie, S, Stanworth, SJ

Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators by Moseby-Knappe, M, Levin, H, Blennow, K, Ullén, S, Zetterberg, H, Lilja, G, Dankiewicz, J, Jakobsen, JC, Lagebrant, A, Friberg, H, Nichol, A, Ainschough, K, Eastwood, GM, Wise, MP, Thomas, M, Keeble, T, Cariou, A, Leithner, C, Rylander, C, Düring, J, Bělohlávek, J, Grejs, A, Borgquist, O, Undén, J, Simon, M, Rolny, V, Piehler, A, Cronberg, T, Nielsen, N

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, ph... by Fisher, BA, Veenith, T, Slade, D, Gaskell, C, Rowland, M, Whitehouse, T, Scriven, J, Parekh, D, Balasubramaniam, MS, Cooke, G, Morley, N, Gabriel, Z, Wise, MP, Porter, J, McShane, H, Ho, L-P, Newsome, PN, Rowe, A, Sharpe, R, Thickett, DR, Bion, J, Gates, S, Richards, D, Kearns, P, Williams, B, Turner, R, Libri, V, Mussai, F, Middleton, G, Bowden, S, Bangash, M, Gao-Smith, F, Patel, J, Sapey, E, Thomas, M, Coles, M, Watkinson, P, Rahman, N, Angus, B, Mentzer, AJ, Novak, A, Feldman, M, Richter, A, Faustini, S, Bathurst, C, Van de Wiel, J, Mee, S, James, K, Rahman, B